TRCT
IMGN

Tower Research Capital (TRC)’s Immunogen Inc IMGN Stock Holding History

Tower Research Capital (TRC)’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-49,870
Closed -$1.48M – 6313
2023
Q4 		$1.48M Buy
49,870
+44,616
+849% +$888K 0.02% 627
2023
Q3 		$83.4K Sell
5,254
-5,768
-52% -$95.9K ﹤0.01% 2115
2023
Q2 		$208K Sell
11,022
-1,186
-10% -$14K 0.01% 1537
2023
Q1 		$47K Sell
12,208
-35,849
-75% -$153K ﹤0.01% 2558
2022
Q4 		$238K Sell
48,057
-55,398
-54% -$300K 0.01% 1198
2022
Q3 		$495K Buy
103,455
+53,856
+109% +$284K 0.01% 1145
2022
Q2 		$223K Buy
49,599
+44,930
+962% +$195K 0.01% 1683
2022
Q1 		$23K Sell
4,669
-19,735
-81% -$109K ﹤0.01% 3415
2021
Q4 		$181K Sell
24,404
-16,828
-41% -$105K ﹤0.01% 1847
2021
Q3 		$234K Buy
41,232
+28,862
+233% +$167K 0.01% 1672
2021
Q2 		$82K Sell
12,370
-9,709
-44% -$67.7K ﹤0.01% 2586
2021
Q1 		$179K Buy
22,079
+16,508
+296% +$135K ﹤0.01% 2109
2020
Q4 		$36K Sell
5,571
-248,183
-98% -$1.45M ﹤0.01% 3438
2020
Q3 		$913K Buy
253,754
+198,801
+362% +$803K 0.01% 1085
2020
Q2 		$253K Buy
+54,953
New +$234K 0.01% 1598
2020
Q1 		– Sell
-253
Closed -$1K – 4124
2019
Q4 		$1K Sell
253
-33,125
-99% -$112K ﹤0.01% 3356
2019
Q3 		$81K Buy
+33,378
New +$88.6K 0.01% 1478
2019
Q2 		– Sell
-384
Closed -$1K – 4462
2019
Q1 		$1K Sell
384
-1,226
-76% -$5.31K ﹤0.01% 3655
2018
Q4 		$8K Sell
1,610
-4,025
-71% -$24.4K ﹤0.01% 2647
2018
Q3 		$53K Buy
+5,635
New +$54.2K ﹤0.01% 1723
2018
Q2 		– Sell
-6,779
Closed -$71K – 4173
2018
Q1 		$71K Buy
6,779
+6,480
+2,167% +$64K 0.01% 1475
2017
Q4 		$2K Sell
299
-269
-47% -$1.66K ﹤0.01% 3261
2017
Q3 		$4K Buy
+568
New +$3.77K ﹤0.01% 3424
2017
Q1 		– Sell
-9,632
Closed -$20K – 4096
2016
Q4 		$20K Buy
+9,632
New +$19.3K ﹤0.01% 2162
2016
Q1 		– Sell
-109
Closed -$1K – 5130
2015
Q4 		$1K Sell
109
-17,003
-99% -$209K ﹤0.01% 4203
2015
Q3 		$164K Buy
17,112
+964
+6% +$14.1K 0.02% 340
2015
Q2 		$232K Sell
16,148
-20,975
-57% -$230K 0.02% 307
2015
Q1 		$332K Buy
37,123
+18,454
+99% +$134K 0.04% 234
2014
Q4 		$114K Buy
18,669
+18,266
+4,533% +$167K 0.01% 540
2014
Q3 		$4K Buy
+403
New +$4.56K ﹤0.01% 3481
2013
Q4 		– Sell
-3,387
Closed -$58K – 5006
2013
Q3 		$58K Buy
3,387
+2,639
+353% +$46.4K 0.01% 1781
2013
Q2 		$12K Buy
+748
New +$12.1K ﹤0.01% 2218

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tower Research Capital (TRC)'s IMGN Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 49,870 shares — an estimated $1.48M sold.

Tower Research Capital (TRC) first reported a position in IMGN in Q2 2013 and held it in 32 quarters. The position peaked at $1.48M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Tower Research Capital (TRC) reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 49,870 Immunogen Inc shares in Q1 2024, an estimated $1.48M.
  • Tower Research Capital (TRC) first reported a position in Immunogen Inc in Q2 2013 and held it in 32 quarters.
  • Tower Research Capital (TRC)'s Immunogen Inc position peaked at $1.48M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.